Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Clinical trial NCT04339777 · RECRUITING

Trial details

NCT number: NCT04339777
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoproliferative Disorders Autoimmune Lymphoproliferative Immune System Diseases Common Variable Immunodeficiency Primary T-cell Immunodeficiency Disorders

Start date: 2020-09-22
Primary completion: 2026-10-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.